Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

919 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Microalbuminuria development in short-term IDDM.
González-Clemente JM, Esmatjes E, Navarro P, Ercilla G, Casamitjana R, Rios M, Levy I, Gomis R, Vilardell E. González-Clemente JM, et al. Among authors: navarro p. Diabetes Res Clin Pract. 1994 May;24(1):15-23. doi: 10.1016/0168-8227(94)90081-7. Diabetes Res Clin Pract. 1994. PMID: 7924882
The effect of hyperglycemia on glipizide absorption in NIDDM patients.
Esmatjes E, Vinuesa P, Navarro P, Rodriguez-Villar C, Gomis R, Vilardell E. Esmatjes E, et al. Among authors: navarro p. Diabetes Care. 1995 Jul;18(7):1075-6. doi: 10.2337/diacare.18.7.1075. Diabetes Care. 1995. PMID: 7555547 No abstract available.
Congenital panhypopituitarism of late onset.
Navarro P, Halperin I, Rodríguez C, González JM, Vidal J, Vilardell E. Navarro P, et al. J Endocrinol Invest. 1994 May;17(5):347-50. doi: 10.1007/BF03348997. J Endocrinol Invest. 1994. PMID: 8077619
[Paralysis associated with weight loss].
Navarro P, González-Clemente JM, Grau F, Gomis R. Navarro P, et al. Med Clin (Barc). 1994 Jan 22;102(2):76. Med Clin (Barc). 1994. PMID: 8133704 Spanish. No abstract available.
Real-world short-term effectiveness of ustekinumab in 305 patients with Crohn's disease: results from the ENEIDA registry.
Iborra M, Beltrán B, Fernández-Clotet A, Gutiérrez A, Antolín B, Huguet JM, De Francisco R, Merino O, Carpio D, García-López S, Mesonero F, Navarro P, Ferreiro-Iglesias R, Carbajo AY, Rivero M, Gisbert JP, Piñero-Pérez MC, Monfort D, Bujanda L, García-Sepulcre MF, Martín-Cardona A, Cañete F, Taxonera C, Domènech E, Nos P; GETECCU Group (Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa). Iborra M, et al. Among authors: navarro p. Aliment Pharmacol Ther. 2019 Aug;50(3):278-288. doi: 10.1111/apt.15371. Epub 2019 Jun 20. Aliment Pharmacol Ther. 2019. PMID: 31222872
Clinical features, therapeutic requirements and evolution of patients with Crohn's disease and upper gastrointestinal involvement (CROHNEX study).
Sainz E, Zabana Y, Miguel I, Fernández-Clotet A, Beltrán B, Núñez L, García MJ, Martín-Arranz MD, Iglesias E, Cañete F, Gutiérrez A, Piqueras M, Pérez-Martínez I, Bujanda L, Rodríguez-Lago I, Casanova MJ, Navarro P, Vicente R, Merino O, Algaba A, Rodríguez C, Huguet JM, Fernández-Bañares F, Domènech E, Esteve M; ENEIDA registry of GETECCU. Sainz E, et al. Among authors: navarro p. Aliment Pharmacol Ther. 2021 Oct;54(8):1041-1051. doi: 10.1111/apt.16547. Epub 2021 Aug 18. Aliment Pharmacol Ther. 2021. PMID: 34406676
EpidemIBD: rationale and design of a large-scale epidemiological study of inflammatory bowel disease in Spain.
Chaparro M, Barreiro-de Acosta M, Benítez JM, Cabriada JL, Casanova MJ, Ceballos D, Esteve M, Fernández H, Ginard D, Gomollón F, Lorente R, Nos P, Riestra S, Rivero M, Robledo P, Rodríguez C, Sicilia B, Torrella E, Garre A, García-Esquinas E, Rodríguez-Artalejo F, Gisbert JP; EpidemIBD study group of GETECCU. Chaparro M, et al. Therap Adv Gastroenterol. 2019 May 21;12:1756284819847034. doi: 10.1177/1756284819847034. eCollection 2019. Therap Adv Gastroenterol. 2019. PMID: 31205485 Free PMC article.
919 results